Status:
COMPLETED
Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine
Lead Sponsor:
Sanofi Pasteur, a Sanofi Company
Conditions:
Pertussis
Eligibility:
All Genders
Brief Summary
To further characterize the vaccine safety profile and to identify any signals of potentially vaccine-related adverse events (AEs) not detected during pre-licensure studies.
Detailed Description
Surveillance using a healthcare organization with large comprehensive medical encounter databases will be used in this study to identify any risks or uncommon events associated with use of the recentl...
Eligibility Criteria
Inclusion
- Receipt of ADACEL vaccine during the study period
Exclusion
- None
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
327293 Patients enrolled
Trial Details
Trial ID
NCT00258882
Start Date
January 1 2006
End Date
December 1 2012
Last Update
July 17 2018
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Oakland, California, United States
2
Aurora, Colorado, United States
3
Portland, Oregon, United States